The round included participation from new strategic investors:
'The strength and breadth of our investment partners illustrate the impact our solution has across the entire healthcare ecosystem - physicians, payers, pharma, and most importantly, patients,' said
Octave offers a complete precision care solution that combines blood biomarkers, expanded imaging capabilities, and clinical insights for a comprehensive view of the patient, including disease activity levels and disease progression. These objective insights provide providers, payers, pharma, and patients with the tools needed to better measure, monitor, and more effectively manage these conditions. Commercially launched in late 2022, Octave is in use in multiple
'We are impressed with Octave's comprehensive solution and its ability to help address the immense unmet need for patients with neurodegenerative diseases,' said
'Intermountain Ventures is committed to investing in innovative solutions that address unmet clinical needs, and Octave does exactly that for multiple sclerosis patients,' said
The strategic investor mix from across the ecosystem demonstrates the value and support in the Octave solution and its ability to improve the patient care paradigm in neurodegenerative diseases.
About Octave Bioscience
Octave Bioscience is a commercial stage precision-medicine company delivering a new paradigm of care for multiple sclerosis and other neurodegenerative diseases. Octave's Precision Care Solution is the industry's first set of measurement tools that accurately and objectively measure disease activity, progression, and severity, allowing for better management of complex and high-cost neurodegenerative diseases, starting with Multiple Sclerosis (MS). Octave's platform includes the first and only multivariate blood test to measure MS Disease Activity, enhanced MRI analytics and protocols, and a clinical care program that tracks and connects patients with MS nurse practitioners in real time. By combining and analyzing multiple biological and contextual layers of data, delivering longitudinal and holistic perspectives of each patient, and revealing insights at population levels, the Octave Solution addresses unmet needs across the entire ecosystem of care, from patients and providers to pharma and payers. Octave is currently collaborating with leading clinics, payers, and pharma companies across the country.
(C) 2023 Electronic News Publishing, source